Published in Oncol Lett on June 13, 2016
Identification of laryngeal cancer prognostic biomarkers using an inflammatory gene-related, competitive endogenous RNA network. Oncotarget (2016) 0.76
Potential biomarkers for radiosensitivity in head and neck cancers. Ann Transl Med (2016) 0.75
MicroRNA-148a suppresses proliferation and invasion potential of non-small cell lung carcinomas via regulation of STAT3. Onco Targets Ther (2017) 0.75
Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods (2001) 414.27
MicroRNAs: genomics, biogenesis, mechanism, and function. Cell (2004) 198.59
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer (2010) 90.16
MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer. Gynecol Oncol (2008) 11.46
MicroRNAs in body fluids--the mix of hormones and biomarkers. Nat Rev Clin Oncol (2011) 5.46
Circulating microRNA in body fluid: a new potential biomarker for cancer diagnosis and prognosis. Cancer Sci (2010) 5.17
MicroRNA: Biogenesis, Function and Role in Cancer. Curr Genomics (2010) 2.80
miRNA-96 suppresses KRAS and functions as a tumor suppressor gene in pancreatic cancer. Cancer Res (2010) 1.99
Identification of cis- and trans-regulatory variation modulating microRNA expression levels in human fibroblasts. Genome Res (2010) 1.67
MicroRNA-21 acts as an oncomir through multiple targets in human hepatocellular carcinoma. J Hepatol (2010) 1.40
Down-regulation of the microRNA-99 family members in head and neck squamous cell carcinoma. Oral Oncol (2012) 1.36
Down-regulation of MiR-206 promotes proliferation and invasion of laryngeal cancer by regulating VEGF expression. Anticancer Res (2011) 1.26
MicroRNAs are independent predictors of outcome in diffuse large B-cell lymphoma patients treated with R-CHOP. Clin Cancer Res (2011) 1.17
MiR-203 is downregulated in laryngeal squamous cell carcinoma and can suppress proliferation and induce apoptosis of tumours. Tumour Biol (2014) 1.16
Expression of microRNAs in squamous cell carcinoma of human head and neck and the esophagus: miR-205 and miR-21 are specific markers for HNSCC and ESCC. Oncol Rep (2010) 1.14
MicroRNA function and dysregulation in bone tumors: the evidence to date. Cancer Manag Res (2014) 1.07
Transcriptome profiling of the cancer, adjacent non-tumor and distant normal tissues from a colorectal cancer patient by deep sequencing. PLoS One (2012) 1.04
miR-370 targeted FoxM1 functions as a tumor suppressor in laryngeal squamous cell carcinoma (LSCC). Biomed Pharmacother (2013) 1.01
MiR-106b promotes cell proliferation via targeting RB in laryngeal carcinoma. J Exp Clin Cancer Res (2011) 0.99
Regulation of Metastasis by microRNAs in Ovarian Cancer. Front Oncol (2014) 0.97
Interobserver variability of laryngeal mucosal premalignant lesions: a histopathological evaluation. Mod Pathol (2011) 0.96
Influence of pre-diagnostic cigarette smoking on colorectal cancer survival: overall and by tumour molecular phenotype. Br J Cancer (2014) 0.91
Role of microRNA-1 in human cancer and its therapeutic potentials. Biomed Res Int (2014) 0.90
MicroRNA‑34a/c function as tumor suppressors in Hep‑2 laryngeal carcinoma cells and may reduce GALNT7 expression. Mol Med Rep (2014) 0.89
miR-21, miR-106b and miR-375 as novel potential biomarkers for laryngeal squamous cell carcinoma. Curr Pharm Biotechnol (2014) 0.89
Regulation of laryngeal squamous cell cancer progression by the lncRNA H19/miR-148a-3p/DNMT1 axis. Oncotarget (2016) 0.88
The clinical and diagnostic role of microRNAs in ovarian carcinoma. Gynecol Oncol (2014) 0.87
Pre-diagnostic leukocyte genomic DNA methylation and the risk of colorectal cancer in women. PLoS One (2013) 0.86
MicroRNAs: novel biomarkers for gastrointestinal carcinomas. Mol Cell Biochem (2010) 0.82
Evaluation of miR-29c, miR-124, miR-135a and miR-148a in predicting lymph node metastasis and tumor stage of gastric cancer. Int J Clin Exp Med (2015) 0.82
Differentiation therapy for hepatocellular carcinoma: Multifaceted effects of miR-148a on tumor growth and phenotype and liver fibrosis. Hepatology (2016) 0.82
MicroRNA-148a inhibits breast cancer migration and invasion by directly targeting WNT-1. Oncol Rep (2015) 0.81
MicroRNA-148a represents an independent prognostic marker in bladder cancer. Tumour Biol (2015) 0.78
Is severe dysplasia the same lesion as carcinoma in situ? 10-Year follow-up of laryngeal precancerous lesions. Acta Otolaryngol (2012) 0.78
Long-term follow-up and salvage surgery in patients with T2N0M0 squamous cell carcinoma of the glottic larynx following concurrent chemoradiation therapy with cisplatin and 5-fluorouracil for laryngeal preservation. Acta Otolaryngol (2012) 0.77